Skip to main content

Walleye Capital LLC

Position in MYGN — Myriad Genetics Inc

CIK 1758720 NEW YORK, NY

Position in MYGN

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$2,653,134
-$1,511,498 QoQ
Shares Held
464,647
-31.4% QoQ
Ownership
0.486%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#35
of 195 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Derivatives in MYGN

reported options exposure · as of Jun 30, 2026
CallValue
$59,955
CallShares
10,500
PutValue
$3,997
PutShares
700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $25,239,598 across 16 Diagnostics & Research names. MYGN ranks #3 (10.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 MYGN
Myriad Genetics Inc
This page
464,647 $2,653,134

All Filings in MYGN

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,997 700
2026-06-30 $59,955 10,500
2026-06-30 $2,653,134 464,647
2025-12-31 $4,164,632 677,176
2025-09-30 $2,890,966 399,857
2025-09-30 $45,549 6,300
2025-09-30 $723 100
2025-06-30 $134,343 25,300
2025-06-30 $241,456 45,472
2025-03-31 $1,655,159 186,602
2023-12-31 $19,140 1,000
2023-12-31 $38,280 2,000
2023-12-31 $329,743 17,228
2023-09-30 $163,608 10,200
2023-09-30 $5,148 321
2023-09-30 $48,120 3,000
2023-03-31 $607,441 26,149
2022-12-31 $567,718 39,126
2022-09-30 $405,373 21,246
2022-03-31 $399,470 15,852
2021-09-30 $238,332 7,381
2020-09-30 $601,326 46,114
2020-06-30 $247,506 21,826
2020-03-31 $357,463 24,980